Results:289 patients’ preoperative CTA reviewed (1148±328images/patient).Mean CIA narrowest diameters 12.8±4mm(R), 12.9±3.9mm (L)Mean EIA narrowest diameter 7.7±1.6mm(R), 7.8±1.7mm(L)Tortuosity ratios 0.8±0.1(R, L), range 0.40-0.91TASC II C/D lesion PAD in 31 patients (10.7%)No in hospital and 30-day complicationswere recorded@ mean follow-up (26 months):30 reinterventions in 26 patients (8.9%), and 22 (7.6%) non AAA-related deaths
R-EIA diameter ≤5mm (P=.0012, OR 5.2, 95% CI 1.73-15.57), and TASC C/D lesionPAD (P=.03, OR 3.06, 95% CI 1.02-9.20) were significantly related to reinterventions.
TORTUOSITYWASNOTASIGNIFICANTPREDICTOROFADVERSEEVENTS
Vascular and Endovascular Surgery Division, Department of Surgery “P Stefanini”Policlinico Umberto I - “Sapienza” University of Rome
ILIACARTERIESMORPHOLOGICALFEATURESASDETERMINANTOFOUTCOMEAFTERSTANDARDEVARPROCEDURESPasqualino Sirignano, FrancescoSpeziale,LauraCapoccia,WassimMansour,Nunzio Montelione,FrancescoSetacci,GiuseppeGalzerano andCarloSetacci
Objectives:To evaluate the impact of iliac arteries’ diameters, tortuosity, and peripheralvascular asset on outcome of elective EVAR for AAA in 2 high volume centers’experience.
Material and Methods:A retrospective study conducted on a prospectivelycollected database between 2010 and 2012.Factors considered as potentially influencing outcomeswere: iliac axes’ diameters and tortuosity and presence ofTASC II C/D femoro-popliteal disease.Outcome measures were reintervention and mortalityrates at follow-up.
Conclusion:Our experience suggests that diameters of access vesselsand the presence of PAD could affect the outcome ofEVAR.
t SD PR-Torurtuosity 0.38 0.10 .70L-Tortuosity 0.30 0.99 .76R-CIADiameter 0.22 0.61 .83L-CIADiameter 0.23 0.46 .81R-EIADiameter 1.91 0.16 .05L-EIADiameter 0.77 0.16 .44
